Finivi Inc.
- SEC CIK
- 0002101641
- Latest filing
- Jul 9, 2026
PLX holding history
Protalix BioTherapeutics, Inc. in every 13F filed by Finivi Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PLX overviewAll 13F holders of PLXFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −14,544−100.0% | Sold out | Holders |
| Q3 2024 | 14,544 | $14.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 14,544 | $17.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 14,544 | $18.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 14,544 | $25.9K | <0.1% | – | No prior filing | Holders |
| Q1 2022 | – | – | – | – | Not filed | Holders |
| Q4 2021 | 14,544 | $12.1K | <0.1% | – | No prior filing | Holders |